The coronavirus mouse hepatitis virus (MHV) directs the synthesis of viral RNA on discrete membranous complexes that are distributed throughout the cell cytoplasm. These putative replication complexes are composed of intimately associated but biochemically distinct membrane populations, each of which contains proteins processed from the replicase (gene 1) polyprotein. Specifically, one membrane population contains the gene 1 proteins p65 and p1a-22, while the other contains the gene 1 proteins p28 and helicase, as well as the structural nucleocapsid (N) protein and newly synthesized viral RNA. In this study, immunofluorescence confocal microscopy was used to define the relationship of the membrane populations comprising the putative replication complexes at different times of infection in MHV-A59-infected delayed brain tumor cells. At 5.5 h postinfection (p.i.) the membranes containing N and helicase colocalized with the membranes containing p1a-22/p65 at foci distinct from sites of M accumulation. By 8 to 12 h p.i., however, the membranes containing helicase and N had a predominantly perinuclear distribution and colocalized with M. In contrast, the p1a-22/p65-containing membranes retained a peripheral, punctate distribution at all times of infection and did not colocalize with M. By late times of infection, helicase, N, and M each also colocalized with ERGIC p53, a specific marker for the endoplasmic reticulum-Golgi-intermediate compartment. These data demonstrated that the putative replication complexes separated into component membranes that relocalized during the course of infection. These results suggest that the membrane populations within the MHV replication complex serve distinct functions both in RNA synthesis and in delivery of replication products to sites of virus assembly.
INTRODUCTION
The coronavirus mouse hepatitis virus, strain A59 (MHV-A59), contains a 32-kb, single-stranded, positivesense RNA genome. The MHV replicase gene (gene 1) encodes two coamino-terminal polyproteins that are proteolytically processed to yield at least 15 mature proteins ( Fig. 1) Lu et al., 1998; Ziebuhr and Siddell, 1999) . Inhibition of gene 1 polyprotein processing at any time during infection has been shown to inhibit viral RNA synthesis (Kim et al., 1995) , demonstrating an essential role for proteolytically mature gene 1-encoded proteins in coronavirus replication and transcription. Studies of temperature-sensitive mutants of MHV have also implicated these proteins in viral RNA synthesis Leibowitz et al., 1982; Schaad et al., 1990 ). Yet, most of the MHV replicase gene products have no defined functions or sequence homology to known viral or cellular proteins.
Studies of the localization and interactions of MHV replicase proteins in infected cells have provided critical insights into the possible roles for these proteins during viral replication. The localization of replicase gene-encoded proteins to cytoplasmic foci active in viral RNA synthesis has been well documented (Bi et al., 1995 (Bi et al., , 1998 Bost et al., 2000; Denison et al., 1999; Heusipp et al., 1997; Schiller et al., 1998; Shi et al., 1999; van der Meer et al., 1999; Ziebuhr and Siddell, 1999) . In addition, recent confocal microscopy studies have determined that multiple replicase gene proteins are colocalized in these foci at 6.5 h postinfection (p.i.) (Bost et al., 2000) .
Cell fractionation experiments have demonstrated association of the colocalized gene 1-encoded proteins with two membrane populations of distinct density on iodixanol gradients (Sims et al., 2000) . The less dense membrane population was LAMP-1 (lysosome-associated membrane protein 1) positive and contained the p65 and p1a-22 proteins (Sims et al., 2000) . In contrast, the more dense population contained markers for ER as well as LAMP-1-positive membranes. The dense population was associated with the viral helicase (hel), p28, and nucleocapsid (N) proteins (Sims et al., 2000) . In addition, the hel/p28/N-positive membranes contained almost all of the viral RNA synthesized between 6 and 8 h p.i. Finally, it has been shown that the putative replication com-plexes were almost entirely discrete from sites of M accumulation (Bost et al., 2000) . Together, these data suggested that the putative MHV replication complex is multipartite, composed of closely associated membrane populations containing hel/N/p28/RNA and p1a-22/p65, respectively (Sims et al., 2000) , and that the multipartite complexes were distinct from sites of virion assembly.
For simplicity in the current report, the term "complex" will be used to refer to colocalized proteins contained in the discrete membrane populations.
In this study we sought to determine whether the hel/N complexes remain associated with the p1a-22/p65 complexes throughout the infectious cycle in delayed brain tumor (DBT) cells. Experiments were performed to determine whether the localization of the hel/N complexes was altered with respect to the p1a-22/p65 complexes and sites of virion assembly during the course of infection. We demonstrate that the hel/N complexes were extensively colocalized with the p1a-22/p65 complexes at 5.5 h p.i., but by 8 h p.i. the hel/N complexes colocalized with M while the p1a-22/p65 complexes were still detected as peripheral foci entirely distinct from sites of M accumulation. The results of this study suggest that the multipartite nature of the putative MHV replication complex has an important biological implication; the ability to separate into two complexes and translocate one of these complexes to sites of virus budding at late times of infection.
RESULTS
The hel/N complex relocalizes to sites of M accumulation at late times of infection Using hel as a marker for the hel/N/p28/RNA complexes and M as a marker for sites of virion assembly, we sought to determine whether the localization of hel/N complexes changed during the course of infection. DBT cells were mock-infected or infected with MHV-A59 for 5.5, 8, or 12 h and probed with antibodies directed against hel (B1) and M (J.1.3), followed by analysis using confocal immunofluorescence microscopy (Fig. 2) . These times were chosen since we have previously shown that the rate of MHV RNA synthesis is maximal at 5 to 6 h p.i. in DBT cells and production of progeny virus is still active at 12 h p.i. (Kim et al., 1995) .
Neither hel, M, nor N was detected in mock-infected DBT cells ( Fig. 2A) . In MHV-infected cells, hel and M were distinct at 5.5 h p.i., with hel detected as punctate cytoplasmic foci and M as a typical perinuclear "cap." However, when cells were probed at 8 and 12 h p.i., hel and M were no longer distinct, but rather were extensively colocalized (Figs. 2B and 2C) . The colocalization of hel and M was detected in a more prominent perinuclear pattern similar to that seen with M alone at 5.5 h p.i. Although the degree of hel/M colocalization varied from cell to cell in the infected monolayer at each time point, the number of cells with significant hel/M colocalization increased between 6 and 8 h p.i. (data not shown). Hel/M colocalization was predominant by 12 h p.i. We therefore chose 5.5 and 12 h p.i. as the early and late time points for subsequent experiments.
To determine whether hel was relocalizing independent of the complexes containing hel, N, and viral RNA, we investigated whether other components of the complex also relocalized at sites of M accumulation by 12 h p.i. Nucleocapsid protein was chosen since it has previously been shown to colocalize with hel by both confocal immunofluorescence and biochemical fractionation Sims et al., 2000) . When a direct comparison of N and hel localization was performed at 5.5 h p.i., hel and N colocalized in punctate cytoplasmic foci ( Fig. 2C ), in agreement with our previous results . When cells were probed for hel and N at 12 h p.i., hel and N retained their colocalization both in single cells and in syncytia (Fig. 2C ). This result suggested that both hel and N were relocalizing in intact complexes at late times of infection. To demonstrate this directly, the localization of N with respect to M was analyzed at 5.5 and 12 h p.i. At 5.5 h p.i., foci of N were entirely distinct from sites of M concentration, but by 12 h p.i., N was extensively colocalized with M in perinuclear foci, in a pattern indistinguishable from that with hel and M. The N/M colocalization was observed both in individual cells (data not shown) and in syncytia. Together these results demonstrated that the intact membranous complexes containing hel and N were relocalized to sites of M accumulation.
The hel/N complexes and p1a-22/p65 complexes separate at late times of infection
We next sought to determine whether the hel/N complexes remained associated with the p1a-22/p65 complexes throughout infection. MHV-infected cells were fixed at 5.5 and 12 h p.i. and localization of p1a-22 and p65 with respect to M was determined in dual-labeling experiments (Fig. 3) . In mock-infected cells, no signal was detected with ␣p1a-22 or ␣p65, confirming the specificity of the antibodies (Fig. 3A) . In MHV-infected cells, we first demonstrated that p1a-22 and hel colocalized extensively at 5.5 h p.i., a result consistent with our previous studies ( Fig. 3B) (Bost et al., 2000) . When p1a-22 and M were directly compared at 5.5 h p.i., p1a-22 was detected in characteristic punctate cytoplasmic complexes that were completely distinct from the signal for M, typically found in a focused perinuclear pattern ( Fig.  3C ). At 12 h p.i., the pattern of p1a-22 with respect to M was unchanged, remaining completely distinct, and in dramatic contrast to the colocalization of hel and N with M at 12 h p.i. The observed separation of p1a-22 from M was not dependent on cell morphology and was not affected by syncytia formation.
When cells were probed for p65 and M, p65 was detected in a pattern identical to that of p1a-22, with punctate cytoplasmic foci of p65 in a pattern that was distinct from the perinuclear foci of M at all times of infection ( Fig. 3D) . These data confirmed that the p1a-22/p65-associated membranes were physically distinct from the hel/N-associated membranes and showed that the hel/N complexes and the p1a-22/p65 complexes separate during the course of infection.
Relocalization of hel/N complexes to sites of M accumulation does not require new protein synthesis
To demonstrate that the colocalization of hel/N complexes with M at late times postinfection was due to translocation of existing hel/N complexes to sites of M accumulation rather than to de novo synthesis of hel or N at a new location, we analyzed the effect of the translation inhibitor cycloheximide on hel/N relocalization (Fig.  4) . A 100 g/ml concentration of cycloheximide has been previously determined to be sufficient for inhibition of gene 1 translation in coronavirus-infected cells (Kim et al., 1995; Perlman et al., 1987; Sawicki and Sawicki, 1986) . When infected cells were incubated with cycloheximide beginning at 5.5 h p.i. and continuing throughout the remainder of infection, extensive colocalization of hel or N with M was still observed at 12 h p.i. (Figs. 4A  and 4B ). In contrast, p1a-22 and p65 remained distinct from M at 12 h p.i. in the presence of cycloheximide (Figs. 4C and 4D) . These experiments demonstrated that the observed colocalization of the hel/N complexes from 8 to 12 h p.i. was due to translocation of membrane-associated proteins translated prior to 5.5 h p.i. This experiment also showed that the process of translocation did not require ongoing cellular or viral protein synthesis between 5.5 and 12 h p.i.
Hel and M colocalize on endoplasmic reticulum-Golgi-intermediate compartment membranes at late times of infection
Coronavirus budding is known to take place in the endoplasmic reticulum-Golgi-intermediate compartment (ERGIC) (Klumperman et al., 1994; Krijnse-Locker et al., 1994) . We therefore wanted to know whether the ERGIC was the site of colocalization of M with the hel/N complex. We used an antibody directed against ERGIC-p53, a specific marker for the ERGIC (Hauri et al., 2000) , to determine whether the ERGIC was the site of colocalization of hel/N complexes with M. DBT cells were infected for 5.5 h before the medium was changed to DMEM containing cycloheximide. Infected cells were fixed at 12 h p.i. and probed for ERGIC-p53 and either hel or M (Figs. 5A and 5B). At 12 h p.i. both hel and M colocalized with ERGIC-p53. In contrast, when cells were dual-labeled for p1a-22 and ERGIC-p53, p1a-22 was entirely distinct from ERGIC-p53 (Fig. 5C ). These results showed that the hel/N complexes, but not the p1a-22/p65 complexes, were translocated to the MHV budding compartment in the ERGIC.
DISCUSSION
Positive-strand RNA viruses are known to organize replication complexes on the surface of cytoplasmic membranes using a variety of mechanisms and cytoplasmic organelles to organize their replication complexes (Candurra et al., 1999; Froshauer et al., 1988; Nejmeddine et al., 2000; Schlegel et al., 1996; Westaway et al., 1997) . However, several important areas of the cell biology of replication complex formation and function of positivestrand RNA viruses have remained undefined. One area critical to understanding virus-host interaction during replication is the changes that occur in viral replication complexes over time. This is important since biochemical and physical changes in the replication complexes may correlate with different stages of RNA transcription, replication, encapsidation, or assembly. The second question concerns the relationship of replication complexes to sites of virus assembly in cells. This is a particularly intriguing area since several positive-strand RNA viruses, such as the alphaviruses and flaviviruses, target replication complexes to sites that are distinct from those of virus assembly, raising questions about how newly synthesized RNA is delivered to these sites of assembly. Therefore, understanding the dynamic virushost interactions is critical to a comprehensive understanding of replication.
In this study we have shown that there are temporal changes in the organization, association, and localization of the membrane/protein/RNA complexes that together comprise the putative mouse hepatitis virus replication complexes. Our previous confocal and biochemical experiments strongly argued that the membrane/ protein complexes active in MHV RNA synthesis were in fact composed of two independent membrane populations containing distinct replicase (gene 1) proteins (Bost et al., 2000; Sims et al., 2000) . The experiments in this study have demonstrated the physical separation of the hel/N and p1a-22/p65 complexes and relocalization of the hel/N complex during the course of infection, thus confirming in a compelling fashion that the MHV replication complexes are composed of physically distinct but closely associated membrane/protein populations. To our knowledge this is the first description of a multipartite replication complex with distinct temporal patterns of association and separation. The results have important implications for our study and understanding of the regulation of coronavirus RNA synthesis and virion assembly.
Localization of the hel/N complex and viral RNA
Our results show that the localization of both hel and N changes during the course of infection, characterized by decreasing interaction with the p1a-22/p65 complex and increasing colocalization with a marker for virion assembly, the structural protein M. Since we previously demonstrated that hel, N, p28, and newly synthesized viral RNA segregate to the same membrane population (Sims et al., 2000) , our present study strongly suggests that viral RNA and the p28 protein are also delivered with hel and N to the ERGIC. We have detected MHV RNA metabolically labeled with BrUTP at sites entirely distinct from the p1a-22/p65 complex at 6 to 8 h p.i. (data not shown); however, it has been more difficult to directly show the translocation of newly synthesized genomic RNA. We presume this is because it would require shut-off of all viral RNA synthesis at 5-6 h p.i., tracking of RNA synthesized before inhibition of RNA synthesis, and stability of RNA over a 3-to 6-h period. Further, it has been reported that viral nucleocapsids are rapidly incorporated into virions and exported from the cell, so that localizing amounts of RNA necessary for detection at late times may be difficult. We are currently using a combination of metabolic labeling, RNA fluorescence in situ hybridization, and immuno-EM approaches to investigate the specific association of genomic RNA with the hel/N complex, as well as the predicted translocation of viral nucleocapsids for assembly over time.
Continued protein expression is not required for separation and translocation of the hel/N complex
Relocalization of the hel/N complexes occurred in the presence of inhibitory concentrations of cycloheximide, demonstrating that continued viral or cellular protein synthesis after 5.5 h p.i. was not required for separation or translocation of the complexes. Since addition of cycloheximide has been shown to result in the rapid shutoff of viral RNA synthesis when added at any time during infection (Kim et al., 1995; Perlman et al., 1987; Sawicki and Sawicki, 1986; Shi et al., 1999) , our experiments further suggest that continued RNA synthesis after 5.5 h may not be required for hel/N complex translocation. The separation and translocation observed may therefore be the result of viral or cellular processes or signals that are already under way prior to inhibition of viral protein or RNA synthesis. This is a reasonable possibility since MHV RNA synthesis also begins to decline by 6-8 h p.i. in untreated cells (Kim et al., 1995) . It should be possible to answer this question by investigating inhibition of viral or cellular protein or RNA synthesis at earlier times in infection.
Mechanisms of translocation of hel/N complexes
Another question that has arisen from our experiments is the mechanism of translocation of the hel/N complexes. We have previously reported that the membranes with which hel, N, RNA, and p28 segregate contain enzymatic activity found in membranes of the endoplasmic reticulum (ER) (NADPH-cytochrome C reductase) (Sims et al., 2000) . If the ER is the sole or major membrane component of hel/N complexes, then "normal" ER-to-ERGIC trafficking pathways would provide an established mechanism that MHV might exploit to deliver replication products to sites of assembly. It is interesting that the presence of distributed punctate ERGIC or "ER exit sites" has been recently described (Rossanese et al., 1999) and that the pattern of expression of these sites is reminiscent of the MHV replication complexes at 5 to 6 h p.i. (Bost et al., 2000; Shi et al., 1999; van der Meer et al., 1999) . ER-to-ERGIC movement appears to be an ongoing process of migration of ER "packets" along microtubular highways in normal cells except in the presence of specific inhibitors (Thyberg and Moskalewski, 1999) . Thus the temporal change in hel/N complex association with the p1a-22/p65 complex and the rather specific transition to separation and translocation suggest a regulated process. Since new virus is detected in the supernatant medium of MHV-infected DBT cells before the change in hel/N complex localization is observed, it is likely that translocation of smaller packets of hel/N complexes is occurring earlier than 6 h p.i. The prominent alteration in hel/N complex localization detected in this study may represent a more comprehensive transition from replication to assembly.
It is also possible that endosome-to-ERGIC trafficking could account for some or all hel/N complex translocation, since late endosomes have been implicated as sites for viral RNA synthesis , and markers for endosomes have been detected in gradient fractions containing the hel/N/p28/RNA complexes (Sims et al., 2000) . There is no precedent for direct trafficking from endosomes to ERGIC; rather it is thought that endosome-to-ER trafficking occurs via retrograde movement through the Golgi. Specifically, Rab 9-mediated movement from endosomes to the trans-Golgi network (TGN) results in fusion of endosomes with the TGN (Lombardi et al., 1993) . The endosome cargo is then available for movement by retrograde transport mechanisms from the TGN to the ERGIC (White et al., 1999) . Identification of the membranes in the hel/N complex will be useful as a basis for investigating specific pathways of cellular transport.
Implications of hel/N complex translocation for virion assembly
Delivery of the hel/N complexes to sites of virus assembly also might serve an important function in assembly. In addition to serving as a potential mechanism for delivery of newly synthesized RNA, hel/N migration could serve as a retention signal for M in the ERGIC. Narayanan et al. (2000) have recently reported specific M-N interactions at 8 h p.i. in a pre-Golgi compartment; however, they were unable to re-create this interaction in cells overexpressing M and N. They speculated that a MHV-specific action is required for this interaction (Narayanan et al., 2000) . Our experiments would support the conclusion that the missing MHV action is the translocation of the hel/N complex. Additionally, it was reported that N was associated with all genomic and subgenomic RNA species, but only N in association with genome length RNA was able to be coimmunoprecipitated with M (Narayanan et al., 2000) . Thus hel/N complex translocation provides an attractive model for regulation of packaging of complete viral nucleocapsids.
Model of coronavirus replication complex shuttling to sites of virion assembly
The events between coronavirus entry and assembly appear to involve a dynamic process of changing protein/membrane interactions. Based on our data, we propose a model in which virus-cell interactions may be divided into temporally distinct stages (Fig. 6 ). The early stage (0 to 6 h p.i.) is characterized by gene 1 replicase protein expression, maturation, and targeting to biochemically separate but intimately associated membrane populations in discrete foci within the cell cytoplasm. These interacting membrane populations are sites for viral RNA synthesis, with the timing of maximal detection of the interacting membrane/protein complexes corresponding to times of maximal viral RNA synthesis. During this stage, newly synthesized viral RNA associates specifically with the membrane population containing hel, N, and p28 (Bost et al., 2000; Kim et al., 1995; Shi et al., 1999; . Finally, during the early stage, M protein can be detected in perinuclear and cytoplasmic foci discrete from the putative replication complexes. During the intermediate stage (6 to 8 h p.i.), the translocation of hel/N complexes to the ERGIC is first observed. The late stage (8 to 12 h p.i.) is characterized by extensive separation of the hel/N complexes from the p1a-22/p65 complexes and colocalization of hel/N complexes with the ERGIC and M. This late stage is temporally associated with decreasing rates of new viral RNA synthesis and maximal rates of new virus production. We speculate that these temporal associations are not coincidental but rather reflect specific transitions in the virus life cycle from replication to assembly. This would further indicate that the association of p1a-22/p65 complexes with hel/N complexes is required for RNA synthesis and that the separation and translocation of the hel/N complexes result in both shutoff of RNA synthesis and delivery of viral nucleocapsids to sites of virion budding.
The results of this study will provide the foundation for studies of the mechanisms of replication complex formation, function, and translocation. The link between stages of replication and detectable virus cell interactions should allow us to define viral and cellular proteins and pathways involved in each stage of MHV replication.
MATERIALS AND METHODS

Antibodies
The anti-hel (B1), anti-p1a-22, and anti-p65 antisera were generated in rabbits and have been previously published Lu et al., 1998; Sims et al., 2000) . The anti-M (J.1.3) and anti-N (J.3.3) monoclonals were provided by John Fleming (University of Wisconsin, Madison), and anti-ERGIC was obtained from Hans-Peter Hauri (University of Basel, Switzerland).
Virus infection and confocal immunofluorescence assays.
DBT cells on glass coverslips were mock-infected or infected with MHV A59 (Hirano et al., 1976) at a multiplicity of infection of 10 plaque-forming units per cell. Infections were performed at 37°C in Dulbecco's modified Eagle's medium (DMEM) containing 6% fetal calf serum (FCS). In all experiments using cycloheximide, the virus inoculant was removed from the cells at 5.5 h p.i. and replaced with DMEM containing 6% FCS and 100 g/ml cycloheximide (Sigma). DMEM in parallel mockinfected wells was also replaced with cycloheximidecontaining medium at 5.5 h p.i. At the times indicated, cells were washed in 1ϫ Tris and fixed in Ϫ20°C 100% methanol. Cells were then rehydrated in phosphate-buffered saline (PBS) containing 5% bovine serum albumin (BSA). For dual-labeling studies using one primary antibody derived from rabbit and the other from mouse, primary antisera were combined in diluent containing PBS with 2% goat serum, 1% BSA, and 0.05% NP-40 and were incubated with the rehydrated cells for 1 h at room temperature. Primary polyclonal sera were all used at a final 1:100 dilution for each antibody, and the monoclonal anti-N (J.3.3), anti-M (J.1.3), and anti-ERGIC antibodies were each diluted 1:500. After being washed in PBS/1% BSA/0.05% NP-40, cells were incubated at room temperature for 1 h with a 1:1000 dilution of anti-rabbit and/or anti-mouse secondary antisera conjugated to Alexa 488 or Alexa 546 dyes (Molecular Probes). The final antibody incubation for all cells was followed by washing in PBS/1% BSA/0.05% NP-40. Cells were then washed with PBS, rinsed with H 2 O, and mounted in Aquapolymount (Polysciences, Inc.) on glass slides. Immunofluorescence was detected at 488 and 543 nm using a 40ϫ oil immersion objective on the Zeiss LSM 410 confocal microscope in the Shared Imaging Resource of the Vanderbilt Ingram Cancer Center. Differential interference contrast (DIC) images were obtained using the 488-nm laser. For images shown in color, red and green were artificially assigned to the grayscale images using the huesaturation option in Adobe Photoshop 5.0.
